Published: July 24th 2024 | Updated: July 27th 2024
Eye on Pharma: BI Cyltezo Partnership; Europe Ustekinumab Launch; Mexico Biosimilar Approval
Published: March 5th 2024 | Updated: July 27th 2024
FDA Approves First Denosumab Biosimilars
Published: April 14th 2021 | Updated: July 27th 2024
Poll: What Is the Best Way to Improve Biosimilar Access?
Published: May 12th 2024 | Updated: July 27th 2024
Jeffrey Casberg Predicts Generic, Biosimilar Competition in the Pharmaceutical Market
Published: June 23rd 2024 | Updated: July 27th 2024
IPD Analytics' Jeffrey Casberg Says IRA, PBM Legislation Reshape US Drug Costs
Published: June 30th 2024 | Updated: July 27th 2024
Jeffrey Casberg of IPD Analytics Gives Insight on Specialty Drugs in the Pipeline